Abstract
IntroductionThe GLOBAL LEADERS is an open-label, pragmatic and superiority randomised controlled trial designed to challenge the current treatment paradigm of dual antiplatelet therapy (DAPT) for 12 months followed by aspirin...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have